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Introduction
Treatment options for breast and prostate cancer decrease
significantly after a tumor metastasizes. Metastasis can be
triggered by an inflammation response.
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3. Amylose Column

2. Expression

0.5 mM IPTG
Let grow
overnight

The plasmid for the IC is mixed with
E.coli Cells; heat shocking causes E.coli
to pick up plasmid

Sonication is used to lyse cells. Amylose
column is used to separate IC construct
(70 kDa) from cell debris

Adding IPTG to the cell culture
induces expression of the
inflammatory cytokine

Conclusion
The biggest challenge when purifying the IC is the
electrostatic attraction to the M BP. The M BP and IC
tend to ''stick'' together despite using cation
exchange chromatography. Before size exclusion
chromatography can be performed, there must be a
minimal amount of
MBP present in the sample. Our current research
aims to decrease these interactions in order to
obtain pure, bioactive protein.
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An inflammatory cytokine (IC) serves as a primary signal in
this pathway. The overall goal of this project is to find a
molecule capable of inhibiting the IC to prevent metastasis
from occurring
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A cation exchange column is used to
separate the IC from the maltose-binding
protein and 6-his tag
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HRV 3C protease is used to cleave
binding site, separating IC from maltose
binding protein and 6-his tag
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3C cleavage site: allows the Maltose binding protein
and 6-histidines to be removed from IC
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IC construct appears at ~70 kDa. Differences between the
pellet and supernatant lane demonstrates successful
isolation from E. Coli cells. After running the supernatant
over the amylase column, construct is separated from
most of cell debris
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Size exclusion chromatography is
used to ensure a pure, bioactive
sample of the IC is obtained

can cause tumors to become established in a secondary

Our lab works to design a protocol to express and purify
large, milligram quantities of the IC to be used to
determine the structure of the binding site and find a small
molecule inhibitor (SMI) capable of inhibiting the protein.
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Once tumor cell reaches circulation in the blood stream, it

4. Cleavage

5. Cation exchange (5)
column

After decreasing these interactions, our next step is
to isotopically label the protein using a minimal
media containing isotopically labeled nitrogen and
carbon. These proteins will be run through NMR to
further characterize the binding site .

Cation exchange chromatography separates IC from full
construct (~70 kDa) that is still intact but fails to separate
IC (~20 kDa) from the cleaved M BP tag (~40 kDa).
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